menu
    • menu

    Company profile for Spago Nanomedical

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Spago Nanomedical is a Swedish biotechnology company developing nanomaterials for cancer diagnostics and treatment. The company´s two main projects, SpagoPix and Tumorad, are both based on the same proprietary nanomaterial. SpagoPix is a gadolinium-free contrast agent for magnetic resonance imaging (MRI) with exceptionally high signal strength. By selectively accumulating in tumor tissue via passive tumor targeting, SpagoPix...
    Spago Nanomedical is a Swedish biotechnology company developing nanomaterials for cancer diagnostics and treatment. The company´s two main projects, SpagoPix and Tumorad, are both based on the same proprietary nanomaterial. SpagoPix is a gadolinium-free contrast agent for magnetic resonance imaging (MRI) with exceptionally high signal strength. By selectively accumulating in tumor tissue via passive tumor targeting, SpagoPix meets a well recognized need for significantly improved soft tissue tumor imaging. Tumorad is a nanoprticle loaded with radionuclides being developed to target soft tissue tumors for radiopharmaceutical treatment.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Spago NanomedicalSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Scheelevägen 22 SE-223 63 Lund
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://spagonanomedical.se/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/spago-imaging-ab/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spago Nanomedical's Tumorad Abstract Accepted At Conference
    Spago Nanomedical's Tumorad Abstract Accepted At Conference

    24 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-24/spago-nanomedical-s-abstract-on-tumorad-accepted-for-presentation-at-radiopharma-conference

    PHARMIWEB
    24 Mar 2026
    Share Share
    Spago Nanomedical Bolsters CMC, Supply for Tumorad's Next Phase
    Spago Nanomedical Bolsters CMC, Supply for Tumorad's Next Phase

    10 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-10/spago-nanomedical-strengthens-cmc-and-supply-capabilities-to-support-next-phase-of-tumorad-developme

    PHARMIWEB
    10 Mar 2026
    Share Share
    Spago Nanomedical 2025 Year-End Report
    Spago Nanomedical 2025 Year-End Report

    05 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-05/spago-nanomedical-year-end-report-january-december-2025

    PHARMIWEB
    05 Feb 2026
    Share Share
    Spago Nanomedical Appoints Nomination Committee For AGM 2026
    Spago Nanomedical Appoints Nomination Committee For AGM 2026

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/nomination-committee-appointed-for-spago-nanomedicals-annual-general-meeting-2026

    PHARMIWEB
    08 Dec 2025
    Share Share
    Spago Nanomedical Reveals Results Of Oversubscribed Rights Issue
    Spago Nanomedical Reveals Results Of Oversubscribed Rights Issue

    24 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-24/spago-nanomedical-announces-outcome-of-oversubscribed-rights-issue

    PHARMIWEB
    24 Nov 2025
    Share Share
    Spago Nanomedical Starts Subscription Period For Rights Issue
    Spago Nanomedical Starts Subscription Period For Rights Issue

    07 Nov 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-11-07/the-subscription-period-in-spago-nanomedicals-rights-issue-begins-today

    PHARMIWEB
    07 Nov 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search